Skip to content
  • About Us
    • Who We Are
    • Our Team
    • Our Advisors
    • Investors & Partners
  • Science
    • Prescription Digital Therapeutics
    • Product Pipeline
  • Products
    • PearConnect
    • reSET® & reSET-O®
    • Somryst®
  • News
    • Press Releases
    • Pear in the News
  • Careers
    • Our Values
    • Our Culture
    • Open Positions
Contact Us
Pear Therapeutics

Press Releases

Media Contact

news@peartherapeutics.com

Press Releases

  • Pear Therapeutics Announces Publication of Economic Analysis Showing Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder February 23, 2021
  • Pear Announces Indiana Family and Social Services Administration Division of Mental Health and Addiction will Provide Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders February 17, 2021
  • Pear Therapeutics to Participate in BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 10, 2021
  • Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment January 13, 2021
  • Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD) December 11, 2020
  • Pear Therapeutics Completes $80M Series D Financing Led by SoftBank Vision Fund 2 December 8, 2020
More
Pear Therapeutics
  • Boston
    200 State Street
    Boston, MA 02109
  • San Francisco
    201 Mission Street
    San Francisco, CA 94105
  • Email Us
  • © 2021 Pear Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Code of Conduct